DJIA 16,262.56 89.32 0.55%
NASDAQ 4,034.16 0.00 0.00%
S&P 500 1,842.98 12.37 0.68%
market minute promo

NxStage Medical

NASDAQ: NXTM

12.04 -0.86 (-6.67%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

NXTM $12.04 -6.67%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $12.93
Previous Close $12.90
Daily Range $11.54 - $12.93
52-Week Range $8.77 - $15.00
Market Cap $737.1M
P/E Ratio -41.61
Dividend (Yield) $0.00 (0.0%)
Volume 925,513
Average Daily Volume 660,805
Current FY EPS -$0.41

Sector

Healthcare

Industry

Healthcare Information Services

NxStage Medical (NXTM) Description

A medical device company, which develops, manufactures and markets innovative systems for the treatment of end-stage renal disease and acute kidney failure. Website: http://www.nxstage.com/

News & Commentary Rss Feed

Is It Time to Buy These 4 Dialysis Stocks?

Should you consider buying these four dialysis stocks -- DaVita, Fresenius, NxStage, and Rockwell -- since the Centers for Medicare and Medicaid Services changed its tune on reducing payments to kidney dialysis providers?

NxStage Medical Breaks Below 200-Day Moving Average - Notable For NXTM

Commit To Buy NxStage Medical At $12.50, Earn 16.2% Annualized Using Options

Despite skepticism, market technicals remain bullish

NxStage Medical, Inc. Discusses Q4 2013 Results (Webcast)

Sector Update: Healthcare Shares Flat to Lower Pre-Market; Pacira Up 5% on Phase 3 Trial Meeting End

Sector Update: Healthcare Shares Flat to Lower Pre-Market; Pacira Up 5% on Phase 3 Trial Meeting Endpoints

Sector Update: Healthcare

NxStage Medical (NXTM) Shares Cross Below 200 DMA

NxStage Medical CEO Presents at JPMorgan Healthcare Conference (Transcript)

3 Stocks Spiking on Big Volume

NxStage Gaining Ground On Growing Adoption Of Home Hemodialysis

See More NXTM News...

NXTM's Top Competitors

NXTM $12.04 (-6.67%)
Current stock: NXTM
$0.00 (0.00%)
Current stock:
MDT $58.05 (-0.05%)
Current stock: MDT
COV $69.90 (-0.03%)
Current stock: COV